Creator: Noémie Fouarge, EMJ, London, UK
Quotation: EMJ Repro Well being. 2026;12[1]:29-32. https://doi.org/10.33590/emjreprohealth/DX25VIZW
IN MAY 2026, polycystic ovary syndrome (PCOS) was renamed polyendocrine metabolic ovarian syndrome (PMOS) following a world consensus led by Monash College, Melbourne, Australia; the Androgen Extra & PCOS (AE-PCOS) Society; and Verity PCOS UK, Surrey, UK. On the European Society of Human Replica and Embryology (ESHRE) Congress 2026, a session titled ‘Renaming PCOS: governance, consensus course of, outcomes and world implementation’ explored the whys, hows, and impacts of this variation for sufferers worldwide. The session was chaired by Alessandra Alteri, Saint Camillus Worldwide College of Well being Sciences, Rome, Italy; and Katerina Bambang, The Delphi Clinic, Liverpool, UK, and featured three audio system from the PCOS Title Change Committee.
WHY THE NAME MATTERS
Anju Joham, Monash College, defined that PMOS is a situation characterised by endocrine adjustments, together with insulin resistance, which is current in 75–95% of affected ladies; gonadotropin-releasing hormone pulsatility adjustments, resulting in luteinising hormone and follicle-stimulating hormone imbalance; elevated anti-Müllerian hormone (AMH), which causes follicular arrest; adipokine dysregulation; and insulin-like development issue signalling points.1 The identify PCOS implies that the pathology lies with the ovaries. Nonetheless, Joham defined, this terminology may trigger hurt, as analysis has proven that the options of the situation are a lot broader. Piltonen et al.2 studied the ovarian options of the situation, and their findings confirmed that the situation is related to polycystic ovary morphology, with elevated ovarian quantity and elevated follicles, that are deceivingly known as cysts. Nonetheless, the research confirmed that there was no distinction in benign or pathological cysts between the 2 teams, suggesting that there isn’t a elevated threat of cysts in sufferers with PMOS.2
Additional analysis has proven a clustering of metabolic options in sufferers with PMOS, with an elevated threat of diabetes, dyslipidaemia, insulin resistance, and hypertension.1 Moreover, information have proven an elevated threat of cardiovascular occasions, together with main hostile cardiovascular occasions, myocardial infarction, angina, and wish for revascularisation, unrelated to weight problems.3 A subsequent research of Nordic ladies with PMOS confirmed that in ladies with a BMI decrease than 25 kg/m2, cardiovascular threat was elevated.4
A global evidence-based guideline, printed in 2023, which appeared on the evaluation and administration of the situation, helps the endocrine and metabolic origins of the situation, with a variety of options manifesting throughout the lifespan.5 In adolescence, probably the most outstanding signs are an growing BMI and psychological burden, whereas reproductive years are marked by subfertility, being pregnant problems, and extra vital metabolic options. Put up-menopause, the situation doesn’t disappear, and metabolic options begin to predominate. The rules additionally characteristic up to date diagnostic standards for PMOS, with the primary change being the addition of AMH, which can be utilized in lieu of polycystic ovary morphology on ultrasound. For adults, two of the next are actually required for analysis: oligo- or anovulation; medical and/or biochemical hyperandrogenism; and polycystic ovaries or elevated AMH ranges. In adolescents, each oligo-or anovulation and medical and/or biochemical hyperandrogenism have to be current. Since ovarian adjustments are anticipated as a part of regular pubertal improvement, it’s endorsed to not use polycystic ovary morphology for analysis, or to incorporate AMH ranges, as these don’t peak till early 20s.
Joham concluded that the time period PCOS is a misnomer, specializing in a single organ whereas ignoring the wide selection of endocrine, metabolic, psychological, and dermatological results of the situation. This mislabelling not solely impacts well being outcomes but additionally coverage, funding, analysis, training, and care.
THE ROAD TO CONSENSUS
In 2012, Joham defined, a workshop was held to vary the identify, however as a result of lack of world management, affected person alignment, settlement on another identify, and implementation methods, the method stalled. The brand new initiative addressed these limitations, beginning with a survey of practically 8,000 sufferers and HCPs, confirming that the identify was inaccurate and wanted to be modified. This was adopted by a major session course of, which checked out data gaps, and a workshop on the AE-PCOS Society Annual Assembly in 2023, which endorsed the identify change. Lastly, they carried out one other survey with 22,000 members, exhibiting overwhelming help for a reputation change. All through this course of, 56 organisations have been concerned throughout six continents, overlaying a variety of disciplines, together with gynaecology, endocrinology, dermatology, metabolic well being, psychology, and vitamin.
The following step was to determine on a brand new identify that might mirror the span of the situation, get rid of the deceptive time period ‘cysts’, scale back reproductive stigma, and recognise the vary of metabolic, psychological, and cardiometabolic options, whereas facilitating implementation. PMOS was chosen as an correct, symptom-based time period that frames this situation as multidisciplinary, permitting for extra holistic, patient-centred care.6
FROM CONSENSUS TO CLINICAL PRACTICE
Terhi Piltonen, Oulu College Hospital, Finland, defined that this variation now must be carried out in any respect ranges, together with coverage, analysis, training, and care. To make sure this, they’ve created a 3-year, eight-step implementation technique, with an embedded analysis technique to watch world uptake. This begins with the general public dissemination by means of publications; the creation of sources on a world scale; content material shared by means of media and social media; updating well being info techniques; notifying researchers, funders, journals, and databases; worldwide classification by means of an up to date Worldwide Classification of Illnesses (ICD) code; training, from world conferences to universities; and revising worldwide tips. Most of those are already underway, with 25 publications up to now throughout a variety of journals, thousands and thousands of individuals reached throughout social media, and the Nationwide Institute for Well being and Care Excellence (NICE) Tips having already adopted the brand new time period.
THE PATIENT VOICE
Rachel Morman, Affected person Advocate and Chair of Verity PCOS UK, the UK’s main affected person charity for PMOS, emphasised that greater than 14,000 ladies with PMOS, from all around the world, contributed to this consensus and have been integral to the method by co-designing surveys, co-chairing workshops alongside HCPs, shaping governance, and bringing real-world multicultural views. “The historical past of ladies’s well being is plagued by selections made about ladies’s well being with out ladies concerned, and this was very a lot completely different, and it ought to set the bar for future situation identify adjustments to return,” mentioned Morman. The identify change was capable of occur as a result of sufferers, clinicians, and researchers who needed higher, and cared deeply, refused to surrender. Whereas they didn’t create proof, they created an setting the place the proof may now not be ignored, and this was the inspiration of the identify change.
Ultimately, 86% of sufferers and 76% of HCPs supported the change, and 97% of workshop members agreed on the ultimate identify, exhibiting a democratic, globally knowledgeable resolution. Morman concluded by sharing the story of Victoria, who was identified with PMOS in her 40s because of the identify change, and who has already skilled an enchancment in high quality of life since beginning therapy, exhibiting the influence that that is already having on affected person care.
CONCLUSION
PMOS impacts 170 million folks of reproductive age worldwide, and it’s estimated that greater than 70% of ladies with PMOS are undiagnosed. The transition from PCOS to PMOS is not only a change in terminology however displays a broader change in how the situation is known and validates affected person experiences. Whereas the change is not going to, by itself, change care, it lays the inspiration for extra correct analysis and higher care worldwide.
